摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9,10-dihydro-9,10-ethano-anthracen-11-ylamine | 6372-65-2

中文名称
——
中文别名
——
英文名称
9,10-dihydro-9,10-ethano-anthracen-11-ylamine
英文别名
9,10-Dihydro-9,10-aethano-anthracen-11-ylamin;7-Amino-dibenzobicyclo<2.2.2>octadien;7-Aminodibenzobicyclo<2.2.2>octadien;9.10-(11-Aminoethano)-9.10-dihydroanthracen;9,10-Dihydro-9,10-ethanoanthracen-11-amine;tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaen-15-amine
9,10-dihydro-9,10-ethano-anthracen-11-ylamine化学式
CAS
6372-65-2
化学式
C16H15N
mdl
——
分子量
221.302
InChiKey
URRYLKCWJQMOQX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    17
  • 可旋转键数:
    0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    26
  • 氢给体数:
    1
  • 氢受体数:
    1

SDS

SDS:1dfc206cf3deb58b41aab02b97ced3c3
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • New triazine derivatives as potent modulators of multidrug resistance
    作者:Alain Dhainaut、Gilbert Regnier、Ghanem Atassi、Alain Pierre、Stephane Leonce、Laurence Kraus-Berthier、Jean Francois Prost
    DOI:10.1021/jm00091a017
    日期:1992.6
    A series of 70 triazine derivatives have been synthesized and tested for their capacity to modulate multidrug resistance (MDR) in DC-3F/AD and KB-A1 tumor cells in vitro, in comparison with verapamil (VRP), a calcium channel antagonist currently used in therapy as an antihypertensive drug, which also shows MDR modulating activity. Among the 12 selected compounds, 16 (S9788) showed high MDR reversing properties in vitro (300- and 6-fold VRP at 5-mu-M in DC-3F/AD and KB-A1 cells, respectively) and induced a strong accumulation of adriamycin. The relationship between the increase of ADR accumulation and the fold reversal induced by these compounds and their lack of effects on the sensitive DC-3F cells suggest that they act mainly by inhibiting the P-glycoprotein (Pgp) catalyzed efflux of cytotoxic agents, as already described for a majority of MDR modulators. In vivo, in association with the antitumor drug vincristine (0.25 mg/kg), 16 (100 mg/kg) increased the TIC by 39% in mice bearing the resistant tumor cell line P388/VCR. According to these interesting properties, 16 was selected for a clinical development because it was more bioavailable than 34, even though it was less active.
  • Geometry−Affinity Relationships of the Selective Serotonin Receptor Ligand 9-(Aminomethyl)-9,10-dihydroanthracene
    作者:Scott P. Runyon、Srinivas Peddi、Jason E. Savage、Bryan L. Roth、Richard A. Glennon、Richard B. Westkaemper
    DOI:10.1021/jm010354g
    日期:2002.4.1
    With the exception of its two aromatic rings and basic nitrogen atom, 9-(aminomethyl)-9,10-dihydroanthracene (AMDA; 1) is remarkably devoid of the pharmacophore features usually associated with high-affinity receptor ligands such as the heteroatom hydrogen bonding features of the endogenous ligand serotonin. AMDA does contain a phenylethylamine skeleton within a tricyclic ring system, and the presence of the second aromatic group is necessary for optimal receptor affinity. The structural requirements for the binding of AMDA at 5-HT2A receptors were investigated with respect to the geometric relationship between the two aromatic rings. It appears that the geometry of the AMDA parent is in the optimal range for fold angle between aromatic moieties. Evaluation of conformationally constrained derivatives of AMDA suggests that a chain extended trans, gauche form is most likely responsible for high affinity.
  • The Diels-Alder Reaction of Anthracene with Nitroölefins. A New Route to 11-Nitro- and 11-Amino-9,10-dihydro-9,10-ethanoanthracenes<sup>1</sup>
    作者:Wayland E. Noland、Howard I. Freeman、M. Scott Baker
    DOI:10.1021/ja01582a053
    日期:1956.1
  • RIPOLL J. L.; LEBRUN H.; THUILLIER A., TETRAHEDRON, 1980, 36, NO 17, 2497-2503
    作者:RIPOLL J. L.、 LEBRUN H.、 THUILLIER A.
    DOI:——
    日期:——
  • CHUNG, YONGSEOG;DUERR, BROOK F.;MCKELVEY, TIMOTHY A.;NANJAPPAN, P.;CZARNI+, J. ORG. CHEM., 54,(1989) N, C. 1018-1032
    作者:CHUNG, YONGSEOG、DUERR, BROOK F.、MCKELVEY, TIMOTHY A.、NANJAPPAN, P.、CZARNI+
    DOI:——
    日期:——
查看更多

同类化合物

齐斯托醌 黄决明素 马普替林杂质E(N-甲基马普替林) 马普替林杂质D 马普替林 颜料黄199 颜料黄147 颜料黄123 颜料黄108 颜料红89 颜料红85 颜料红251 颜料红177 颜料紫27 顺式-1-(9-蒽基)-2-硝基乙烯 阿美蒽醌 阳离子蓝3RL 长蠕孢素 镁蒽四氢呋喃络合物 镁蒽 锈色洋地黄醌醇 锂钠2-[[4-[[3-[(4-氨基-9,10-二氧代-3-磺基-1-蒽基)氨基]-2,2-二甲基-丙基]氨基]-6-氯-1,3,5-三嗪-2-基]氨基]苯-1,4-二磺酸酯 锂胭脂红 链蠕孢素 铷离子载体I 铝洋红 铂(2+)二氯化1-({2-[(2-氨基乙基)氨基]乙基}氨基)蒽-9,10-二酮(1:1) 钾6,11-二氧代-6,11-二氢-1H-蒽并[1,2-d][1,2,3]三唑-4-磺酸酯 钠6,11-二氧代-6,11-二氢-1H-蒽并[1,2-d][1,2,3]三唑-4-磺酸酯 钠4-({4-[乙酰基(乙基)氨基]苯基}氨基)-1-氨基-9,10-二氧代-9,10-二氢-2-蒽磺酸酯 钠2-[(4-氨基-9,10-二氧代-3-磺基-9,10-二氢-1-蒽基)氨基]-4-{[2-(磺基氧基)乙基]磺酰基}苯甲酸酯 钠1-氨基-9,10-二氢-4-[[4-(1,1-二甲基乙基)-2-甲基苯基]氨基]-9,10-二氧代蒽-2-磺酸盐 钠1-氨基-4-[(3-{[(4-甲基苯基)磺酰基]氨基}苯基)氨基]-9,10-二氧代-9,10-二氢-2-蒽磺酸酯 钠1-氨基-4-[(3,4-二甲基苯基)氨基]-9,10-二氧代-9,10-二氢-2-蒽磺酸酯 钠1-氨基-4-(1,3-苯并噻唑-2-基硫基)-9,10-二氧代蒽-2-磺酸盐 醌茜隐色体 醌茜素 酸性蓝127:1 酸性紫48 酸性紫43 酸性兰62 酸性兰25 酸性兰182 酸性兰140 酸性兰138 酸性兰 129 透明蓝R 透明蓝AP 透明红FBL 透明紫BS